Gadofosveset Trisodium; Schembl12298216; 2-[[2-[Bis(Carboxymethyl)Amino]-3-[(4,4-Diphenylcyclohexyl)Oxy-Hydroxyphosphoryl]Oxypropyl]-[2-[Bis(Carboxymethyl)Amino]Ethyl]Amino]Acetic Acid; Gadolinate(3-),[[(4R)-4-[Bis[(Carboxy-Ko)Methyl]Amino-Kn]-6,9-Bis[(Carboxy-Ko)Methyl]-1-[(4,4-Diphenylcyclohexyl)Oxy]-1-Hydroxy-2-Oxa-6,9-Diaza-1-Phosphaundecan-11-Oicacid-Kn6,Kn9,Ko11] 1-Oxidato(6-)]-, Sodium (1:3), (Sa-8-11252634)-; Cid 9919137

Brief Introduction

The molecular formula of 2-[[2-[bis(carboxymethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-hydroxyphosphoryl]oxypropyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid is C33H44N3O14P.

Metrizoic Acid

MSDS

CAS:1949-45-7

Molecular Formula:C12H11I3N2O4

Alias

More Information

Metrizoesaeure; Triosil-280; 5-Acetamino-3-<N-Acetyl-Methylamino>-2.4.6-Triiod-Benzoesaeure; 3-Acetamido-2,4,6-Triiodo-5-(N-Methylacetamido)Benzoic Acid; Metrizoate; 3-Acetamido-5-(N-Methylacetamido)-2,4,6-Triiodobenzoic Acid; 3,5-Diacetamido-N-Methyl-2,4,6-Triiodobenzoic Acid; Metrizoic; Acide Metrizoique; Acidum Metrizoicum

Brief Introduction

Metrizoic acid (metrizoate) is an ionic contrast agent. Metrizoic acid (metrizoate) shows high osmotic pressure and is at risk of inducing allergic reaction.

1-[(2E,4E,6E,8R)-8-Hydroxy-6-Methyldodeca-2,4,6-Trienoyl]Pyrrolidin-2-One

MSDS

CAS:19504-77-9

Molecular Formula:C17H25NO3

Alias

More Information

Leofungine; Einecs 243-116-9; Variotin; Supral; Pecilocin; Pecilocine [Inn-French]

Brief Introduction

Pecilocin is an antibiotic.

Amiodarone

MSDS

CAS:1951-25-3

Molecular Formula:C25H29I2NO3

Alias

More Information

(2-Butylbenzofuran-3-Yl)(4-(2-(Diethylamino)Ethoxy)-3,5-Diiodophenyl)Methanone; Tranquerone; Sedacoron; Amiodarons; (2-{4-[(2-Butyl-1-Benzofuran-3-Yl)Carbonyl]-2,6-Diiodophenoxy}Ethyl)Diethylamine; 2-Butyl-3-(3,5-Diiodo-4-(2-Diethylaminoethoxy)Benzoyl)Benzofuran; 2-Butyl-3-Benzofuranyl 4-[2-(Diethylamino)Ethoxy]-3,5-Diiodophenyl Ketone; Amidorone; Amiodarona; Atlansil; Sedacorone; Cordarone; Amiodaronum

Brief Introduction

This product is an antiarrhythmic drug. For various atrial and ventricular arrhythmias (including arrhythmias complicated by severe congestive heart failure and acute myocardial infarction); It has obvious effect on patients who are ineffective in taking other antiarrhythmic drugs. The product can also be used for the treatment of coronary heart disease, angina pectoris and chest tightness. The safety range of this product is larger than that of its antiarrhythmic drugs. The LD50 of mice was 160mg / kg by intravenous injection and 50g / kg by oral administration. Therefore, it is a non-toxic drug when treated orally. The common adverse reactions were nausea, vomiting, constipation, bradycardia, rash and so on.

(1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(Ethoxymethyl)-8-Methyl-8- Azabicyclo[3.2.1]Octane

MSDS

CAS:195875-84-4

Molecular Formula:C17H23Cl2NO

Alias

More Information

Tesofensine; Unii-Blh9Ukx9V1; Ns-2330; Blh9Ukx9V1

Brief Introduction

Tesofensine (NS2330) is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity. Tesofensine was originally developed by a Danish biotechnology company, NeuroSearch, who transferred the rights to Saniona in 2014. As of 2015, tesofensine has been discontinued for the treatment of Alzheimer's disease; Parkinson's disease and is in Phase II clinical trials for obesity.

Inquiry (

/ 10

)

Clear All